Clinical Trial Update: HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease [Phase 3]

View source ↗

Summary

Phase 3 HEARD long-term study evaluating histology of the esophagus in acid-related disease has completed, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux, Heartburn | Phase 3 | Status: COMPLETED